Literature DB >> 21685915

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Iñaki Comino-Méndez1, Francisco J Gracia-Aznárez, Francesca Schiavi, Iñigo Landa, Luis J Leandro-García, Rocío Letón, Emiliano Honrado, Rocío Ramos-Medina, Daniela Caronia, Guillermo Pita, Alvaro Gómez-Graña, Aguirre A de Cubas, Lucía Inglada-Pérez, Agnieszka Maliszewska, Elisa Taschin, Sara Bobisse, Giuseppe Pica, Paola Loli, Rafael Hernández-Lavado, José A Díaz, Mercedes Gómez-Morales, Anna González-Neira, Giovanna Roncador, Cristina Rodríguez-Antona, Javier Benítez, Massimo Mannelli, Giuseppe Opocher, Mercedes Robledo, Alberto Cascón.   

Abstract

Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date, but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in MAX, the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of MAX alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional MAX mutations and suggested an association with malignant outcome and preferential paternal transmission of MAX mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells and by the amplification of MYCN in neuroblastoma and suggests that loss of MAX function is correlated with metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685915     DOI: 10.1038/ng.861

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  36 in total

1.  Genetics of pheochromocytoma and paraganglioma in Spanish patients.

Authors:  Alberto Cascón; Guillermo Pita; Nelly Burnichon; Iñigo Landa; Elena López-Jiménez; Cristina Montero-Conde; Susanna Leskelä; Luis Javier Leandro-García; Rocío Letón; Cristina Rodríguez-Antona; José Angel Díaz; Emilio López-Vidriero; Anna González-Neira; Ana Velasco; Xavier Matias-Guiu; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo
Journal:  J Clin Endocrinol Metab       Date:  2009-03-03       Impact factor: 5.958

2.  Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Authors:  Alberto Cascón; Cristina Montero-Conde; Sergio Ruiz-Llorente; Fátima Mercadillo; Rocío Letón; Cristina Rodríguez-Antona; Beatriz Martínez-Delgado; Manuel Delgado; Alberto Díez; Adela Rovira; José Angel Díaz; Mercedes Robledo
Journal:  Genes Chromosomes Cancer       Date:  2006-03       Impact factor: 5.006

3.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

4.  Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.

Authors:  Elena López-Jiménez; Gonzalo Gómez-López; L Javier Leandro-García; Iván Muñoz; Francesca Schiavi; Cristina Montero-Conde; Aguirre A de Cubas; Ricardo Ramires; Iñigo Landa; Susanna Leskelä; Agnieszka Maliszewska; Lucía Inglada-Pérez; Leticia de la Vega; Cristina Rodríguez-Antona; Rocío Letón; Carmen Bernal; José M de Campos; Cristina Diez-Tascón; Mario F Fraga; Cesar Boullosa; David G Pisano; Giuseppe Opocher; Mercedes Robledo; Alberto Cascón
Journal:  Mol Endocrinol       Date:  2010-10-27

5.  Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.

Authors:  Li Yao; Francesca Schiavi; Alberto Cascon; Yuejuan Qin; Lucia Inglada-Pérez; Elizabeth E King; Rodrigo A Toledo; Tonino Ercolino; Elena Rapizzi; Christopher J Ricketts; Luigi Mori; Mara Giacchè; Antonella Mendola; Elisa Taschin; Francesca Boaretto; Paola Loli; Maurizio Iacobone; Gian-Paolo Rossi; Bernadette Biondi; José Viana Lima-Junior; Claudio E Kater; Marie Bex; Miikka Vikkula; Ashley B Grossman; Stephen B Gruber; Marta Barontini; Alexandre Persu; Maurizio Castellano; Sergio P A Toledo; Eamonn R Maher; Massimo Mannelli; Giuseppe Opocher; Mercedes Robledo; Patricia L M Dahia
Journal:  JAMA       Date:  2010-12-15       Impact factor: 56.272

6.  Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR).

Authors:  Rosa H Jimenez; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Nicola Neretti; Jennifer A Sanders; John Sedivy; Philip A Gruppuso
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.

Authors:  Yuejuan Qin; Li Yao; Elizabeth E King; Kalyan Buddavarapu; Romina E Lenci; E Sandra Chocron; James D Lechleiter; Meghan Sass; Neil Aronin; Francesca Schiavi; Francesca Boaretto; Giuseppe Opocher; Rodrigo A Toledo; Sergio P A Toledo; Charles Stiles; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Nat Genet       Date:  2010-02-14       Impact factor: 38.330

8.  Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

Authors:  Iñigo Landa; Cristina Montero-Conde; Donatella Malanga; Silvia De Gisi; Guillermo Pita; Luis-Javier Leandro-García; Lucía Inglada-Pérez; Rocío Letón; Carmela De Marco; Cristina Rodríguez-Antona; Giuseppe Viglietto; Mercedes Robledo
Journal:  Endocr Relat Cancer       Date:  2010-06-01       Impact factor: 5.678

9.  c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.

Authors:  José P Vaqué; Belén Fernández-García; Pablo García-Sanz; Nuria Ferrandiz; Gabriel Bretones; Fernando Calvo; Piero Crespo; María C Marín; Javier León
Journal:  Mol Cancer Res       Date:  2008-02       Impact factor: 5.852

10.  A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.

Authors:  Patricia L M Dahia; Ken N Ross; Matthew E Wright; César Y Hayashida; Sandro Santagata; Marta Barontini; Andrew L Kung; Gabriela Sanso; James F Powers; Arthur S Tischler; Richard Hodin; Shannon Heitritter; Francis Moore; Robert Dluhy; Julie Ann Sosa; I Tolgay Ocal; Diana E Benn; Deborah J Marsh; Bruce G Robinson; Katherine Schneider; Judy Garber; Seth M Arum; Márta Korbonits; Ashley Grossman; Pascal Pigny; Sérgio P A Toledo; Vania Nosé; Cheng Li; Charles D Stiles
Journal:  PLoS Genet       Date:  2005-07-25       Impact factor: 5.917

View more
  194 in total

1.  False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.

Authors:  Jay S Fonte; Jeremyjones F Robles; Clara C Chen; James Reynolds; Millie Whatley; Alexander Ling; Leilani B Mercado-Asis; Karen T Adams; Victoria Martucci; Tito Fojo; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2012-02-13       Impact factor: 5.678

Review 2.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

3.  Next-generation sequencing for cancer diagnostics: a practical perspective.

Authors:  Cliff Meldrum; Maria A Doyle; Richard W Tothill
Journal:  Clin Biochem Rev       Date:  2011-11

Review 4.  An update on the genetics of pheochromocytoma.

Authors:  D Karasek; U Shah; Z Frysak; C Stratakis; K Pacak
Journal:  J Hum Hypertens       Date:  2012-05-31       Impact factor: 3.012

Review 5.  Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes.

Authors:  Rodrigo A Toledo; Patricia L M Dahia
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

6.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

7.  Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.

Authors:  Johan Kugelberg; Jenny Welander; Francesca Schiavi; Ambrogio Fassina; Martin Bäckdahl; Catharina Larsson; Giuseppe Opocher; Peter Söderkvist; Patricia L Dahia; Hartmut P H Neumann; Oliver Gimm
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

8.  Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

Authors:  Ivana Jochmanova; April Melody T Abcede; Ruby Jane S Guerrero; Chandy Lou P Malong; Robert Wesley; Thanh Huynh; Melissa K Gonzales; Katherine I Wolf; Abhishek Jha; Marianne Knue; Tamara Prodanov; Naris Nilubol; Leilani B Mercado-Asis; Constantine A Stratakis; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-15       Impact factor: 4.553

9.  Pheochromocytoma and paraganglioma syndromes: genetics and management update.

Authors:  M Lefebvre; W D Foulkes
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

10.  Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.

Authors:  Esmeralda Castelblanco; Maria Santacana; Joan Valls; Aguirre de Cubas; Alberto Cascón; Mercedes Robledo; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.